Low-level laser therapy / photobiomodulation for Tinnitus: What Does the Evidence Show?
Complementary & Alternative
Current evidence
Home ear-lasers are sold online today; the meta-analysis verdict is null — and statistically unlikely to change.
Evidence strength: Limited (2/5) · Tier 5 — weak or unsupported · Evidence independence: Mixed.
Red/near-infrared laser applied to the ear or mastoid, claimed to boost cochlear cell function. Sold as home devices (TinniTool, TINNImed and generic 'red light therapy' products, ~$300–500).
Did tinnitus loudness improve?
None shown. 2020 systematic review with meta-analysis and trial sequential analysis: no significant benefit — and TSA indicates more identical trials are unlikely to change that.
Did tinnitus distress improve?
None shown. Scattered small positive trials against a mostly null literature — classic small-study heterogeneity.
Loudness means the tinnitus percept itself became quieter (psychoacoustic matching or loudness ratings). Distress means questionnaire scores such as THI/TFI, sleep, anxiety or quality of life improved — the sound may be unchanged. A THI/TFI improvement is never evidence the tinnitus got quieter.
How strong is the evidence?
Meta-analytically null with sequential analysis saying it's settled: Tier 5.
Has the result been independently replicated?
Conflicting results. Vendor-affiliated positive trials vs independent meta-analysis finding no benefit.
Independence: Positive trials often vendor-affiliated; the null meta-analysis is independent.
What are the limitations?
- Meta-analysis with trial sequential analysis is null
- Marketing heavily outruns evidence
Conflicts of interest: Several positive trials are vendor-affiliated.
What should patients know about safety?
Safety evidence: Strong. Low physical risk at consumer powers; financial risk is the issue.
Is it available?
Regulatory status: No FDA clearance for tinnitus efficacy; some devices CE-marked. CE marking of a low-risk device is not evidence of efficacy.
Availability: Direct-to-consumer online · Europe: Same (CE-marked devices) · Cost (approx.): $300–500 devices
What the studies found
Low-level laser therapy for tinnitus: meta-analysis with trial sequential analysis
Chen CH, et al. · Brain Sciences · 2020 · N=11 RCTs, N=670 · Meta-analysis + trial sequential analysis
No significant benefit of LLLT on tinnitus severity (MD −2.85, 95% CI −8.99 to 3.28, p=0.362; 11 RCTs, N=670). The authors' own conclusion: the value of LLLT 'remains unclear', in part due to small patient numbers and heterogeneity, and larger studies are called for.
Related treatments
- Acupuncture — The world's most-used complementary tinnitus treatment — low-quality trials say yes, higher-quality analysis…
- Hyperbaric oxygen therapy (HBOT) — Oxygen chambers are sold for tinnitus at hundreds of dollars a session; Cochrane says routine use 'cannot be…
- Cannabis / CBD — 'CBD for tinnitus' is aggressively marketed. There are zero human trials — and population data point the…
- Hypnotherapy — Widely offered privately, often with confident claims — there is no evidence it works for tinnitus.
Evidence last reviewed: 2026-09-03 · Evidence included through: 2026-09-03 · Confidence: high. Open the interactive evidence profile.
This page summarizes published research for education. It is not medical advice; it cannot say what will work for any individual. Discuss treatment decisions with a qualified clinician.